The expenditure associated with diagnostic procedures for influenza in India varies depending on the type of test performed, the laboratory conducting the analysis, and the geographic location. Factors influencing the price include reagent costs, technician expertise, and overhead expenses for the facility. Point-of-care rapid tests generally present a lower cost compared to more complex laboratory-based methods such as polymerase chain reaction (PCR) assays.
Access to affordable and reliable influenza diagnostics is vital for effective disease management within the Indian healthcare system. Accurate and timely identification of influenza cases aids in appropriate treatment decisions, prevents unnecessary antibiotic prescriptions, and facilitates the implementation of public health measures to curb outbreaks. Historically, the availability and pricing of these tests have impacted the accessibility of diagnosis, particularly for individuals in lower socioeconomic strata and rural regions.
